China has decided to scrap quarantine for international passengers arriving in China as it further eases restrictions imposed in the wake of Covid pandemic. Meanwhile, Pfizer's Covid drug will be distributed in Beijing as cases continue to surge.
China's management of COVID-19 will also be downgraded to the less strict Category B from the current top-level Category A, the health authority said in a statement, as the disease has become less virulent and will gradually evolve into a common respiratory infection.